Excitotoxins, aging, and environmental neurotoxins: Implications for understanding human neurodegenerative diseases

Toxicology and Applied Pharmacology

Volumn 134, Issue 1, 1995, Pages 1-17

  Dawson, Ralph ^a   Beal, M Flint ^b   Bondy, Stephen C ^c   Dimonte, Donato A ^d   Isom, Gary E ^e  

^a UNIVERSITY OF FLORIDA   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d PARKINSON S INSTITUTE   (United States)

^e PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 3 NITROPROPIONIC ACID; CYANIDE; EXCITATORY AMINO ACID; EXCITOTOXIN; KAINIC ACID; METAL; METHAMPHETAMINE; NEUROTOXIN; ORGANIC SOLVENT; PESTICIDE;

AGING; CALCIUM HOMEOSTASIS; DEGENERATIVE DISEASE; ENERGY METABOLISM; HUMAN; HUNTINGTON CHOREA; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; REVIEW;

AGING; ANIMAL; ENERGY METABOLISM; ENVIRONMENTAL POLLUTANTS; HUMAN; MITOCHONDRIA; MODELS, BIOLOGICAL; NERVOUS SYSTEM DISEASES; NEUROTOXINS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0029147523     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1006/taap.1995.1163     Document Type: Review

References (156)

1. Ailken P., and Braitmen, D. (1989). The effects of cyanide on neural and synaptic function in hippocampal slices. Netiroloxicology 10, 239-248.
2. Albin R. L., and Greenamyre, J. T. (1992). Alternative excitotoxic hypothesis. Neurology41, 733-738.
3. Alston T. A., Mela, L., and Bright, H. J. (1977). 3-Nitropropionate, the toxic substance of Indigofera. is a suicide inactivator of succinate dehydrogenase. Proc. Nail. Acad. Sei. USA 74, 3767-3771.
4. Ardelt, B. K., Borowitz J. L., and Isom, G. E. (1989). Brain lipid peroxidation and antioxidant protectant mechanisms following acute cyanide intoxication. Toxicology 56, 147-154.
5. Auer, R. N. (1991). Excitotoxic mechanisms, and age-related susceptibility to brain damage in ischemia, hypoglyemia and toxic mussel poisoning. Neurotoxicology 12, 541-546.
6. Beal, M. F. (1992). Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann. Neurol. 31, 1 19-130.
7. Beal, M. F., Brouillet, E., Jenkins, B. G., Ferrante, R. J., Kowall, N. W., Miller, J. M., Storey E., Srivastava, R., Rosen, B. R., and Hyman, B. T. (1993a). Neurochemical and histologic characterization of striata) excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J. Neurosci. 13, 4181-4192.
8. Beal M. F., Hyman, B. T., and Koroshetz W. (1993b). Do defects in mi-tochondrial energy metabolism underlie the pathology of neurodegenerative diseases? Trends Neurosci. 16, 125-131.
9. Benveniste H., Jorgensen M. B., Sanberg M., Christensen T., Hagberg, H., and Diemer, N. H. (1989). Ischemic damage in hippocampal CA1 is dependent on glutamate release and intact innervation from CA3.J Cereh. Wood Flow Mctah. 9, 629-639.
10. Bernath S. (1991). Calcium-independent release of amino acid neurotransmitters: Fact or artifact. Prog. N’eurohiol. 38, 57-91.
11. Bondy S. C. (1995). The relation of oxidative stress and hyperexcitation for neurological disease. Proc. Soc. Fxp. Biol. Med. 208, 337-345.
12. Bondy S. C., and LeBel, C. P. (1993). The relationship between excilotox-icity and oxidative stress in the central nervous system. Free Rad Biol. Med. 14, 633-642.
13. Bose R., Schnell, C. L., Pinsky, C., and Zitko V. (1992). Effects ofexcito-toxins on free radical indices in mouse brain. Toxicol. Tell. 60, 211-219.
14. Bossi S. R., Simpson, J. R., and Isacson, O. (1993). Age dependence of striatal neuronal death caused by mitochondrial dysfunction. NcuroRe-port 4, 73-76.
15. Brouillet, E., Hantraye, P., Dolan R., Leroy-Willig, A., Bottlaender, M., Isacson, O., Maziere, M., Ferrante, R. J., and Beal M. F. (1993a). Chronic administration of 3-nitropropionic acid induced selective striatal degeneration and abnormal choreiform movements in monkeys. Soc. Neurosci. Abstr. 19, 409.
16. Brouillet, E., Jenkins, B. G., Hyman B. T., Ferrante, R. J., Kowall N. W., Srivastava, R., Samanta Roy, D., Rosen B. R., and Beal, M. F. (1993b). Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid., J. Neurochem. 60, 356-359.
17. Brown, A. W., Aldrigde, W. N., Street, B. W., and Verchoyle, R. D. (1979). The behavioral and neuropathologic sequelae of intoxication by tri-methyltin compounds in the rat. Am., J. Pathol. 97, 59-82.
18. Burke S. P., and Nadler, J. V. (1989). Effects of glucose deficiency on glu-tamate/aspartate release and excitatory synaptic responses in the hippocampal CA1 area in vitro. Brain Res. 500, 333-342.
19. Burns, R. S., Chiueh, C. C., Markey, S. P., Ebert, M. H., Jacobowitz, D. M., and Kopin, L. J. (1983). A primate model of parkinsonism: Selective destruction of dopaminergic neurons in the pars compacata of the substantia nigra by A’-methyl-4-phenyl-1, 2, 3.6-te’-ahydropyridine. Proc. Nall. Acad. Sci. USA 80, 4546-4550.
20. Carella, F., Grassi M. P., Savoiardo M., Contri, P., Rapuzzi, B., and Man-goni, A. (1988). Dystonic-Parkinsonian syndrome after cyanide poisoning: Clinical and MR1 findings., J. Neurol. Neurosurg. Psych. 51, 1345-1348.
21. Carlsson, M., and Carlsson A. (1990). Interactions between glutamatergic and monoaminergic systems within the basal ganglia - Implications for schizophrenia and Parkinson’s disease. Trends Neurosci. 13, 272-277.
22. Cassel, G., and Persson, S-A. (1992). Effects of acute lethal cyanide intoxication on central dopaminergic pathways. Pharmacol. Toxicol. 70, 148-151.
23. Chan, P., Di Monte, D. A., Luo, J.-J., DeLanney, L. E., Irwin, I., and Langston J. W. (1994). Rapid ATP loss caused by methamphetamine in the mouse striatum: Relationship between energy impairment and dopaminergic neurotoxicity. J. Neurochem. 62, 2484-2487.
24. Chan, P., Langston, J. W., and DiMonte D. A. (1993a). MK-801 temporarily prevents MPTP-induced acute dopamine depletion and MPP’ elimination in the mouse striatum. J. Pharmacol. Fxp. ’Flier. 267, 1515-1520.
25. Chan, P., Langston, J. VV., Irwin, I., DeLanney L. E., and Di Monte, D. A. (1993b). 2-Deoxyglucose enhances l-methyl-4-phenyl-1, 2.3.6-tetrahv-dropyridine-induced ATP loss in the mouse brain. J. Neurochem. 61, 610-616.
26. Chiba K., Trevor, A. J., and Castagnoli, N., Jr. (1984). Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase. Bio-cltem. Biophys. Bex. Commun. 120, 574-578.
27. Choi, D. W. (1988). Glutamate neurotoxicity and diseases of the nervous system. Neuron 1, 623-634.
28. Choi D. W. (1992). Excitotoxic cell death. J Neurohiol. 23, 1261-1276.
29. Cobo, M., Expósito, L., and Mora, F. (1993). Aging prefrontal cortex and amino acid neurotransmitters: Differential effects produced by electrical stimulation. Neurohiol. Aging 14, 187-190.
30. Coles, C. J., Edmondson D. E., and Singer, T. P. (1979). Inactivation of succinate dehydrogenase by 3-nitropropionate. J. Biol. Chem. 254, 5161-5167.
31. Committee on Neurotoxicology and Models for Assessing Risk, Commission on Life Sciences, National Research Council (1992). Environmental Neurotoxicology. National Academy Press, Washington. D.C.
32. Coyle J. T., and Puttfarcken P. (1993). Oxidative stress, glutamate, and neurodegenerative disorders. Science 262, 689-695.
33. Curtis D. R., Phillis J. W., and Watkins J. C. (1960). The chemical excitation of spinal neurones by certain acidic amino acids., J. Physiol. 150, 656-682.
34. Daw, N. W., Stein P. S. G., and Fox, K. (1993). The role of NMDA receptors in information processing. Annu. Rev. Neurosci. 16, 207-222.
35. Dawson, R., Wallace, D. R., and Meldrum, M. J. (1989). Endogenous glutamate release from frontal cortex of adult and aged rats. Neurohiol. Aging 10, 665-668.
36. Dawson, R., and Wallace, D. R. (1992). Kainic acid-induced seizures in aged rats: Neurochemical correlates. Brain Res. Bull. 29, 459-468.
37. Dawson, R., and Wallace D. R. (1993). Regulation of phosphate-activated glutaminase (PAG) by glutamate analogues. Neurochem. Res. 18, 125-132.
38. Dawson R., Patterson T. A., and Epplcr, B. (1995). Endogenous excitatory amino acid release from brain slices and astrocyte cultures evoked by trimethyltin and other neurotoxic agents. Neurochem. Res. 20, 847-858.
39. Denton, T., and Howard, B. D. (1987). A dopaminergic cell line variant resistant to the neurotoxin l-methyl-4-phenyl-l, 2.3.6-tetrahydropyri-dine. J Neurochem. 49, 622-629.
40. Dexter, D. T., Carter C. J., Wells F. R., Javoy-Agid, F., Agid, Y., Lees, A., Jenner, P., and Marsden, C. D. (1989a). Basal lipid peroxidation in substantia nigra is increased in Parkinson’s disease. J. Neurochem. 52, 381-389.
41. Dexter, D. T., Wells, F. R., Lees, A. J., Agid, F., Agid, Y., Jenner, P., and Marsden, C, D, (1989b). Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson’s disease. J. Neurochem. 52, 1830-1836.
42. DiMauro, S. (1993). Mitochondrial involvement in Parkinson’s disease: The controversy continues. Neurology 43, 2170-2172.
43. Di Monte D. A. (1991). Mitochondrial DNA and Parkinson’s disease. Neurology 41 (Suppl. 2), 38-42.
44. Di Monte D. A., Chan P., and Sandy, M. S. (1992). Glutathione in Parkinson’s disease: A link between oxidative stress and mitochondrial damage?, 4nn. Neurol. 32, S111-S115.
45. (1986)Di Monte, D., Jewell, S. A., Ekstrom G., Sandy M. S., and Smith, M. T. l-methyl-4-phenyl-l, 2, 3, 6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP*) cause rapid ATP depletion in isolated hepatocytes. Biochem. Biophys. Res Commun. 137, 310-315.
46. Di Monte, D. A., Sandy, M. S., DeLanney L. E., Jewell, S. A., Chan, P., Irwin, L, and Langston. J. W. (1993). Age-dependent changes in mitochondrial energy production in striatum and cerebellum of monkey brain. Neurodegeneration 2, 93-99.
47. Ellison, G., Eison, M. S., Huberman, H. S., and Daniel, F. (1978). Longterm changes in dopaminergic innervation of caudate nucleus after continuous amphetamine administration. Science 201, 276-278.
48. Erecinska, M., and Silver L. A. (1990). Metabolism and role of glutamate in mammalian brain. Prog. Neurohiol. 35, 245-296.
49. Fahn, S., and Cohen, G. (1992). The oxidant stress hypothesis in Parkinson’s disease: Evidence supporting it. Ann. Neurol. 32, 804-812.
50. Fuller, R. W., Hemrick-Luecke S. K., and Ornstein, P. L. (1992). Protection against amphetamine-induced neurotoxicity toward striatal dopamine neurons in rodents by LY274614, an excitatory amino acid antagonist. Neuropharmacology 31, 1027-1032.
51. Gasic, G. P., and Hollmann M. (1992). Molecular neurobiology of glutamate receptors. Annu. Rev Physiol. 54, 507-536.
52. Gibb, J. W., and Kogan, F. J. (1979). Influence of dopamine synthesis on methamphetamine-induced changes in striatal and adrenal tyrosine hydroxylase. Naunyn-Schmiedeberg’s Arch. Pharmacol. 310, 185-187.
53. Gibson, G. E., and Peterson C. (1987). Calcium and the aging nervous system. Neurohiol. Aging 8, 329-343.
54. Gould, D. H., and Gustine D. L. (1982). Basal ganglia degeneration, myelin alterations, and enzyme inhibition in mice by the plant toxin 3-nitropropionicacid. Neuropath. Appl. Biol. 8, 377-393.
55. Gould, D. H., Wilson, M. P., and Hamar D. W. (1985). Brain enzyme and clinical alterations induced in rats and mice by nitroaliphatic toxicants. Toxicol. Lett. 27, 83-89.
56. Graham, D. G. (1978). Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxicquinones. Mol. Pharmacol. 14, 633-643.
57. Grandas F., Artieda J., and Obeso J. (1989). Clinical and CT scan findings in a case of cyanide intoxication. Movement Disorders 4, 188-193.
58. Halliwell B. (1989). Protection against tissue damage in vivo by desferri-oxaminc: What is its mechanism of action? Free Rad Biol. Med. 7, 645-651.
59. Halliwell, B., and Gutteridge, J. M. C. (1989). Free Radicals in Biology and Medicine. 2nd cd., pp. 266-270. Oxford Press, Oxford.
60. Hamilton, B. F., and Gould, D. H. (1987a). Nature and distribution of brain lesions in rats intoxicated with 3-nitropropionic acid: A type of hypoxic (energy deficient) brain damage. Acta Neuropat hot. 72, 286-297.
61. Hamilton, B. F., and Gould D. H. (1987b). Correlation of morphologic brain lesions with physiologic alterations and blood-brain harrier impairment in 3-nitropropionic acid toxicity in rats. Acta Neuropathol. 74, 67-74.
62. Henneberry, R. C., Novelli, A., Cox, J. A., and Lysko, P. G. (1989). Neurotoxicity at the A-methyl-iaspartate receptor in energy-compromised neurons. An hypothesis for cell death in aging and disease. Ann. N.Y. Acad. Sci. 568, 225-233.
63. Hoyer, S. (1990). Brain glucose and energy metabolism during normal aging. Aging 2, 245-258.
64. Javitch J. A., D’Amato, R. J., Strittmatter, S. M., and Snyder, S. M. (1985). Parkinsonism-inducing neurotoxin, A-methyl-4-phenyl-l, 2, 3, 6-tetrahydropyridine: Uptake of the metabolite A-methyl-4-phenylpyri-dine by dopamine neurons explains selective toxicity. Proc. Natl. Acad. Set. USA 82, 2173-2177.
65. Jenkins, B., Koroshetz, W., Beal, M. F., and Rosen, B. (1993). Evidence for an energy metabolism defect in Huntington’s disease using localized proton spectroscopy. Neurology 43, 2689-2695.
66. Johnson J. D., Meisenheimer, T. L., and Isom, G. E. (1986). Cyanide-induced neurotoxicity: Role of neuronal calcium. Toxicol. Appl. Pharmacol. 84, 464-469.
67. Kanthasamy, A. G., Maduh, E. U., Peoples, R. W., Borowitz, J. L., and Isom, G. E. (1991). Calcium mediation of cyanide-induced catecholamine release: Implications for neurotoxicity. Toxicol. Appl Pharmacol. 110, 275-282.
68. Kanthasamy A. G., Borowitz, J. L., Pavlakovic G., and Isom G. E. (1994a). Dopaminergic neurotoxicology of cyanide: Neurochemical, histological, and behavioral characterization. Toxicol. Appl. Pharmacol. 126, 156-163.
69. Kanthasamy, A. G., Rathinavelu, A., Borowitz, J. L., and Isom, G. E. (1994b). Interaction of cyanide with a dopamine metabolite: Formation of a cyanohydrin adduct and its implications for cyanide-induced neurotoxicology. Neurotoxicology 15, 887-895.
70. Kato, T., Kameyama, M., Nakamura, S., Inada, M., and Sugiyama, H. (1985). Cyanide metabolism in motor neuron disease. Ada Neurol. Stand. 72, 151-156.
71. Kihara, M., and Kubo, T. (1989). Aspartate aminotransferase for synthesis of transmitter glutamate in the medulla oblongata: Effect of aminooxy-acetic acid and 2-oxoglutarate. J. Neurochem. 52, 1127-1134.
72. Kish, S. J., Morito, C., and Hornykiewicz O. (1985). Glutathione peroxidase activity in Parkinson’s disease brain. Ncurosci. Leu. 58, 343-346.
73. Klockgether, T., and Turski, L. (1990). A-Methyl-D-aspartate antagonists potentiate antiparkinsonian actions of L-dopa in monoamine-depleted rats. Ann. Neurol. 28, 539-546.
74. Klockgether, T., and Turski, L. (1993). Toward an understanding of the role of glutamate in experimental parkinsonism: Agonist-sensitive sites in the basal ganglia. Ann. Neurol. 34, 585-593.
75. Lafon-Cazal, M., Pietri, S., Culcasi, M., and Bockaert, J. (1993). NMDA-dependent superoxide production and neurotoxicity. Nature 364, 535-537.
76. Landfield, P. W., Thibault, O., Mazzanti, M. L., Porter N. M., and Kerr, D. S. (1992). Mechanisms of neuronal death in brain aging and Alzheimer’s disease: Role of endocrine-mediated calcium dyshomeostatis. J. Neurohiol. 23, 1247-1260.
77. Langston, J. W., Ballard, P. A., Tetrud, J. W., and Irwin, I. (1983). Chronic parkinsonism in humans due to a product of meperidine analog synthesis. Science 219, 979-980.
78. Langston, J. W., Irwin, I., Langston, E. B., and Forno, L. S. (1984). 1-Methyl-4-phenyl-pyridinium ion (MPP*): Identification of a metabolite of MPTP, a toxin selective to the substantia nigra. Neurosci. Leu. 48, 87-92.
79. Lee, P., Sylvia, A., and Pinatadosi, C. (1988). Cyanide-related changes in cerebral oxygen delivery and metabolism in fluorocarbon-circulated rats. Toxicol. Appl. Pharmacol. 93, 34-44.
80. Lipton, S. A., and Rosenberg, P. A. (1994). Excitatory amino acids as a final common pathway for neurologic disorders. N. Eng. J. Med. 330, 613-622.
81. Lucas D. R., and Newhouse J. P. (1957). The toxic effect of sodium t-glutamate on the inner layers of the retina. AMA Arch. Ophthalmol. 58, 193-201.
82. Ludolph A. C., Langen, K. J., Regard, M., Herzog, H., Kemper B., Ku-wert, T., Bottger, I. G., and Feinendegen, L. (1992a). Frontal lobe function in amyotrophic lateral sclerosis: A neuropsychologic and positron emission tomography study. Acta Neurol Stand. 85, 81-89.
83. Ludolph, A. C., Seelig, M., Ludolph, A., Novitt, P., Allen, C. N., Spencer, P. S., and Sabri, M. I. (1992b). 3-Nitropropionic acid decreases cellular energy levels and causes neuronal degeneration in cortical explants. Neurodegeneration 1, 155-161.
84. Ludolph, A. C., He, F., Spencer, P. S., Hammerslad, J., and Sabri, M. (1991). 3-Nitropropionic acid -Exogenous animal neurotoxin and possible human striatal toxin. Can. J. Neurol. Sci. 18, 492-498.
85. Maduh E. J., Borowitz, J. L., Turek, J. J., Rebar, A., and Isom G. E. (1990). Cyanide induced neurotoxicity: Calcium mediation of morphological changes in neuronal cells. Toxicol. Appl. Pharmacol. 103, 214-221.
86. Maduh E. U., Johnson, J. D., Ardelt, B. K., Borowitz J. L., and Isom, G. E. (1988). Cyanide-induced neurotoxicity: Mechanisms of attenuation by chlorpromazine. Toxicol. Appl. Pharmacol. 96, 60-67.
87. Magnusson, K. R., and Cotman, C. W. (1993). Effects of aging on NMDA and MK801 binding sites in mice. Brain Res. 604, 334-337.
88. Markey, S. P., Johannessen J. N., Chiueh, C. C., Burns R. S., and Her-kenham, M. A. (1984). Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism. Nature 311, 464-467.
89. Matsumoto, M., Inagaki, M., Kiuchi, Y., Izumi, Y., Yamazaki Y., and Oguchi K. (1993). Role of calcium ions in dopamine release induced by sodium cyanide perfusion in rat striatum. Neuropharmacology 32, 681-688.
90. McCord J. M. (1987). Oxygen-derived radicals: A link between reperfusion injury and inflammation. Fed. Proc. 246, 2402-2406.
91. Meldrum, M. J., Glenton P., and Dawson, R. (1992a). [3H]-D-Aspartic acid release in brain slices of adult and aged Fischer 344 rats. Neurochem. Res. 17, 151-156.
92. Meldrum, M. J., Moran P., and Dawson R. (1992b). Regulation of glutamate release in aging. In Treatment oj Dementias (E. M. Meyer et al. Eds.) pp. 407-425. Plenum, New York.
93. Mills, E. M., and Isom, G. E. (1994). The induction of apoptosis in differentiated PCI 2 cells by cyanide. Toxicologist 14, 362.
94. Minotti G., and Aust S. D. (1989). The role of iron in oxygen radical mediated lipid peroxidation. C’ltem. Biol. Interact. 71, 1-19.
95. Mizuno Y., Matuda S., Yoshino, H., Mori H., Hattori N., and Ikebe S.-I. (1994). An immunohistochemical study of o-ketoglutarate dehydrogenase complex in Parkinson’s disease. Ann. Neurol. 35, 204-210.
96. Montastruc, J. L., Rascol, O., Senard J. M., and Rascol, A. (1992). A pilot study of, V-methyl-D-aspartate (NMDA) antagonist in Parkinson’s disease.J Neurol. Neurosurg. Psych. 55, 630-631.
97. Muraki, A., Koyama T., Nakavama M., Ohmori, T., and Yamashita I. (1992). MK-801, a non-competitive antagonist of NMDA receptor, prevents methamphetamine-induced decrease of striatal dopamine uptake sites in the rat striatum. Neurosci. Leu. 136, 39-42.
98. Naalsund L. U., and Fonnum, F. (1986). The effect of trimethyltin on three glutamergic and gabaergic transmitter parameters in vitro: High affinity uptake, release and receptor binding. Neurotoxicologyl, 53-62.
99. Nakanishi, S. (1992). Molecular diversity of glutamate receptors and implications for brain function. Science 258, 597-603.
100. Nash, J. F., and Yamamoto B. K. (1992). Methamphetamine neurotoxicity and striatal glutamate release: Comparison to 3.4-methylenediozy-methamphetamine. Brain Res 581, 237-243.
101. Nicholls, D. G. (1993). Theglutamatergic nerve terminal. Fur. J. Biochem. 212, 613-631.
102. Nicholls, D., and Attwell D. (1990). The release and uptake of excitatory amino acids. Trends Pharmacol Sci. 11, 462-468.
103. Nicklas, W. J., Vyas, I., and Heikkila, R. E. (1985). Inhibition of NADH-linked oxidation in brain mitochondria by l-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, l-methyl-4-phenyl-1.2.3.6-tetrahydro-pyridine. Life Set. 36, 2503-2508.
104. Novelli, A., Reilly, J. A., Lysko, P. G., and Henneberry, R. C. (1988). Glutamate becomes neurotoxic via the V-methyl-D-aspartate receptor w hen intracellular energy levels are reduced. Brain Res. 451, 205-212.
105. O’Dell, S. J., Weihmuller F. B., and Marshall, J. F. (1991). Multiple methamphetamine injections induce marked increases in extracellular striatal dopamine which correlate with subsequent neurotoxicity. Brain Res. 564, 256-260.
106. Okabe, E., Sugihara, M., Tanaka, K., Sasaki, H., and Ito, H. (1989). Calmodulin and free oxygen radicals: Interaction with steady-state calcium accumulation and passive calcium permeability of cardiac asarcoplas-mic reticulum. J Pharmacol. Exp. Thcrap. 250, 286-292.
107. Oliver C. N., Starke-Reed, P. E., Stradtman, E. R., Liu, G. J., Carney, J. M., and Floyd, R. A. (1990). Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ischemia/reperfusion-induced injury to gerbil brain. Proc. Natl. Acad. Sci. USA 87, 5144-5147.
108. Olney J. W. (1980). Excitotoxic mechanisms of neurotoxicity. In Experimental and Clinical Neurotoxicology (V. S. Spencer and El. H. Schaumb-erg, Eds.), pp. 272-294, Williams and Wilkins. Baltimore.
109. Palmer, A. M., Robichaud, P. J., and Rieter, C. T. (1994). The release and uptake of excitatory amino acids in rat brain: Effects of aging and oxidative stress. Neurobiot. Aging 15, 103-111.
110. Patel, M. N., Yim, G. K. W., and Isom, G. E. (1992). Blockade of N-methyl-D-aspartate receptors prevents cyanide-induced neuronal injury in primary hippocampal culture. Toxicol. Appl. Pharmacol. 115, 124-129.
111. Patel, M. N., Yim, G. K. W., and Isom, G. E. (1993). A-methyl-D-aspartate receptors mediate cyanide-induced cytotoxicity in hippocampal cultures. Neurotoxicology 14, 35-40.
112. Pellegrini-Giampeitro, D. E., Cherici, G., Alesiani, M., Caria, V., and Moroni, F. (1990). Excitatory amino acid release and free radical formation may cooperate in the genesis of ischemia-induced neuronal damage. J Neurosci. 10, 1035-1041.
113. Pellerin L., and Wolfe, L. S. (1991). Release of arachidonic acid by NMDA-receptor activation in the rat hippocampus. Neurochem. Res. 16, 983-989.
114. Perry, T. L., Godin, D. V., and Hansen S. (1982). Parkinson’s disease: A disorder due to nigral glutathione deficiency? Neurosci. Lett. 33, 305-310.
115. Persson S-A., Cassal, G., and Sellstrom, A. (1985). Acute cyanide intoxication and central transmitter systems. Fundum. Appl. Toxicol. 5, S150-S159.
116. Petlerson, J., and Cohen, S. (1985). Antagonism of cyanide poisoning by chlorpromazine and sodium thiosulfate. Toxicol. Appl. Pharmacol. 81, 265-273.
117. Rajeswari, T. S., and Radha, E. (1984). Metabolism of the glutamate group of amino acids in rat brain as function of age. Mech. Aging Dev. 24, 139-149.
118. Ramsay, R. R., and Singer, T. P. (1986). Energy-dependent uptake of N-methyl-4-phenylpyridinium. the neurotoxic metabolite of l-methyl-4-phenyl-l.2, 3, 6-tetrahydropyridine. by mitochondria. J. Biol. Chem. 261, 7585-7587.
119. Richter, C., and Kass, G. E. N. (1991). Oxidative stress in mitochondria: Its relationship to cellularCa2* homeostasis, cell death, proliferation and differentiation. Chem. Biol. Interact. 77, 1-23.
120. Riepe, M., Hori, N., Ludolph, A. C., Carpenter, D. O., Spencer, P. S., and Allen, C. W. (1992). Inhibition of energy metabolism by 3-nitropropio-nic acid activates ATP-sensitive potassium channels. Brain Res. 586, 61-66.
121. Rosenberg, N. L., Myers, J. A., and Martin, W. R. W. (1989). Cyanide-induced Parkinsonism: Clinical. MRI and 6-fluorodopa PET studies. Neurology 3S, 142-144.
122. Schapira, A. H. V., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., and Marsden, C. D. (1990). Mitochondrial complex 1 deficiency in Parkinson’s disease. J. Neurochem. 54, 823-827.
123. Seiden, L. S., Fischman M. W., and Schuster, C. R. (1975). Long-term methamphetamine-induced changes in brain catecholamines in tolerant rhesus monkeys. Drug Alcohol Depend. 1, 215-219.
124. Seiler, N. (1993). Is ammonia a pathogenetic factor in Alzheimer’s disease? Neurochem. Res. 18, 235-245.
125. Shoffner, J. M., Watt, R. L., Juncos, J. L., Torroni, A. T., and Wallace, D. C. (1991). Mitochondrial oxidative phosphorylation defects in Parkinson’s disease. Ann. Neurol. 30, 332-339.
126. Sonsalla, P. K., Nicklas, W. J., and Heikkila, R. E. (1989). Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity. Science 243, 398-400.
127. Sonsalla, P. K., Zeevalk, G. D., Manzino L., Giovanni, A., and Nicklas, W. J. (1992). MK-801 fails to protect against the dopaminergic neuropathology produced by systemic l-methyl-4-phenyl-l, 2, 3.6-tetrahydro-pyridine in mice or intranigral l-methyl-4-phenylpyridinium in rats. J. Neurochem. 58, 1979-1982.
128. Spencer, P. S., Ludolph, A. C., and Kisby, G. E. (1992). Are human neu-rodegenerative disorders linked to environmental chemicals with excitotoxic properties? Ann. N. Y Acad. Sci. 648, 154-160.
129. Spina, M. B., and Cohen, G. (1989). Dopamine turnover and glutathione oxidation: Implications for Parkinson’s disease. Proc. Natl. Acad. Sci. USA 86, 1398-1400.
130. Stadtman, E. R. (1988). Minireview: Protein modification in aging. J Gerontol. 43, B112-B120.
131. Storey, E., Hyman B. T., Jenkins, B., Brouillet, E., Miller, J. M., Rosen B. R., and Beal, M. F. (1992). l-Methyl-4-phenylpyridinium produces excitotoxic lesions in rat striatum as a result of impairment of oxidative metabolism. J. Neurochem. 58, 1975-1978.
132. Storm-Mathisen, J., and Ottersen, O. P. (1988). Anatomy of putative glu-tamatergic neurons. In Neurotransmitters and Cortical Function (Avoli et at., Eds.), pp. 39-70. Plenum, New York.
133. Tamaru M., Yoneda Y., Ogita, K., Shimizu, J., and Nagata, Y. (1991). Age-related decreases of the A-methyl-D-aspartate receptor complex in the rat cerebral cortex and hippocampus. Brain Res. 542, 83-90.
134. Tanner C. M. (1994). Epidemiological clues to the cause of Parkinson’s disease. In Movement Disorders 3 (S. Fahn and C. D. Marsden, Eds.), pp. 124-146. Butterworth-Heinemann, Oxford.
135. Teitelbaum, J. S., Zatorre, R. J., Carpenter, S., Gendron, D., Evans A. C., Gjedde, A., and Cashman, N. R. (1990). Neurologic sequelae of domoic acid intoxication due to the ingestion of contaminated mussels. N. Fngl. J Med. 322, 1781-1787.
136. Turski, L., Bressler, K., Rettig, K. J., Loschmann, P. A., and Wachtel, H. (1991). Protection of substantia nigra from MPP* neurotoxicity by A-methyl-D-aspartate antagonists. Nature 349, 414-418.
137. Uitti, R. J., Rajjput A. H., Ashenhrust E. M., and Rozdilsky, B. (1985). Cyanide-induced Parkinsonism: A clinicopathological report. Neurology 35, 921-925.
138. U.S. Congress, Office of Technology Assessment (1990). Neurotoxicity: Identifying and Controlling Poisons of the Nervous System. U.S. Government Printing Office, Washington, DC.
139. Valenzuela, R., Court, J., and Godoy, J. (1992). Delayed cyanide-induced dystonia. J. Neurol. Neurosurg. Psych. 55, 198-199.
140. van den Pol, A. N., and Trombley, P. Q. (1993). Glutamate neurons in hypothalamus regulate excitatory transmission. J. Neurosci. 13, 2829-2836.
141. Vanella, A., Sorrenti, V., Castorina C., Campisi, A., Di Giacomo, C., Russo, A., and Perez-Polo, J. R. (1992). Lipid peroxidation in rat cerebral cortex during post-ischemic reperfusion: Effect of exogenous antioxidants and Ca2* agonist drugs. Ini. J Dev Neurosci. 10, 75-80.
142. Wagner, G. C., Ricaurte, G. A., Seiden, L. S., Schuster, C. R., Miller, R. J., and Westley, J. (1980). Long-lasting depletion of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine. Brain Res. 181, 151-160.
143. Wallace D. R., and Dawson R. (1990). Effect of age and monosodium-L-glutamate (MSG) treatment on neurotransmitter content in brain regions from male Fischer-344 rats. Neurochem. Res. 15, 889-898.
144. Wallace, D. R., and Dawson, R. (1992). Ammonia regulation of phosphate-activated glutaminase displays regional variation and impairment in the brain of aged rats. Neurochem. Res. 17, 1112-1122.
145. Wallace D. R., and Dawson R. (1993). Regional differences in glutaminase activation by phosphate and calcium in rat brain: Impairment in aged rats and implications for regional glutaminase isozymes. Neuro-ehem. Res. 18, 1271-1279.
146. Way, J. L. (1984). Cyanide intoxication and its mechanism of antagonism. Ann. Rex. Pharmacol. Toxicol. 24, 451-481.
147. Weller, M., and Paul, S. M. (1993). 3-Nitropropionic acid is an indirect excitotoxin to cultured cerebellar granule neurons. Pur. J. Pharm. 248, 223-228.
148. Wenk, G. L., Walker, L. C., Price, D. L., and Cork, L. C. (1991). Loss of NMDA, but not GABA-A, binding in the brains of aged rats and monkeys. A’enrohiol. Aging 12, 93-98.
149. Woods, A. H., and Pendleton L. (1925). Fourteen simultaneous cases of an acute degenerative striatal disease. Arch. Neurol. Psych. 13, 549-568.
150. Wozniak, D. F., Stewart, G. R., Miller, J. P., and Olney, J. W. (1991). Age-related sensitivity to kainate neurotoxicity. Exp. Neurol. 114, 250-253.
151. Wullner U., Young, A. B., Penney, J. B., and Beal M. D. (1994). 3-Nitropropionic acid toxicity in the striatum. J. Neurochem., in press.
152. Yamamoto, H. (1989). Hyperammonemia, increased brain neutral and aromatic amino acid levels and encephalopathy induced by cyanide in mice. Toxicol. Appl. Pharmacol 99, 415-420.
153. Yang, C.-W., and Isom, G. E. (1994). Metabotropic receptor mediated inositol trisphosphate generation: Stimulation by cyanide. Toxicologist 14, 351.
154. Yang, C.-W., Rathinavelu, A., Borowitz, J. L., and Isom, G. E. (1994). Activation of a calcium-and pH-dependent phospholipase A2 by cyanide in PCI 2 cells. Toxicol. Appl. Pharmacol. 124, 262-267.
155. Zhang, Y., Marcillat, O., Guilivi, C., Ernster, L., and Davies, K. J. A. (1990). The oxidative inactivation of mitochondrial electron transport chain components and ATPase. J. Biol. Chcm. 265, 16630-16336.
156. Zuddas, A., Oberto, G., Vaglini, F., Fascetti, F., Fornai, F., and Corsini, G. U. (1992). MK.-801 prevents l-methyl-4-phenyl-l, 2, 3, 6-tetrahydro-pyridine-induced Parkinsonism in primates. J. Neurochem. 59, 733-739.